View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This educational activity is supported by an educational grant from MorphoSys US Inc.

Expert Perspectives in Relapsed/Refractory DLBCL: A Look to the Future of Care

Expert Perspectives in Relapsed/Refractory DLBCL: A Look to the Future of Care

Friday, June 5, 2020

Scientific session: 8:00 PM – 10:00 PM EDT

Location: Live webcast

Expert Perspectives in Relapsed/Refractory DLBCL: Program Overview

Diffuse large B-cell lymphoma (DLBCL) is the most common and aggressive form of non-Hodgkin lymphoma. Current standard approach remains R-CHOP for newly diagnosed patients; however, approximately 1 out of every 2 patients will relapse or have primary refractory disease, making risk assessment crucial to identify patients who will need further interventions. Over the past few years, several novel agents have been approved by the FDA to treat patients with relapsed/refractory DLBCL, with many more targeted therapies under investigation. This rapidly evolving treatment landscape holds promise for improving patient outcomes, yet it can be a challenge to navigate and determine best practices for patient care.

This live webcast will provide expert perspectives on managing patients with DLBCL, with a focus on emerging therapies for the relapsed/refractory setting. The renowned faculty will discuss state-of-the-art approaches in risk stratification and challenges in improving frontline therapy. While stem-cell transplant plays an important role in the management of these patients, many patients are not candidates for transplant due to age, comorbidities, and other factors, creating a critical unmet medical need. The panel will evaluate recent clinical trial data for transplant-ineligible patients with relapsed/refractory DLBCL, including antibodies targeting novel cell-surface antigens, inhibitors of B-cell receptor signaling, and cellular immunotherapy. With a look to the future of care, the expert faculty will discuss next steps needed for patients with relapsed/refractory DLBCL to bridge unmet needs, as well as review related abstracts to be presented at upcoming major society meetings.

Acknowledgement of Commercial Support

This educational activity is supported by an educational grant from MorphoSys US Inc.

Target Audience

This educational activity is directed toward medical oncologists and hematologists involved in the treatment and management of patients with DLBCL. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of DLBCL may also participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe contemporary treatment strategies in multiple lines of DLBCL care and unmet clinical needs in DLBCL management
  • Examine testing approaches to stratify risk and monitor treatment responses among patients with DLBCL
  • Evaluate recent efficacy and safety findings from trials that evaluated novel approaches for patients with relapsed/refractory DLBCL
  • Explain how recent clinical trial evidence in relapsed/refractory DLBCL can be placed in the context of unmet needs in the field and late-stage ongoing studies in multiple lines of DLBCL care

Program Chair

Grzegorz S. Nowakowski, MD
Grzegorz S. Nowakowski, MD
Hematology Specialist
Associate Professor
Mayo Clinic
Rochester, MN


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By